About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Chemotherapy may Not be Necessary in All Patients Post-Hydatidiform Mole Evacuation

Font : A-A+

 Chemotherapy may Not be Necessary in All Patients Post-Hydatidiform Mole Evacuation

Chemotherapy may not always be necessary in women following the removal of hydatidiform mole.

Close surveillance may be sufficient in certain women with high hCG levels 6 months post evacuation of a hydatidiform mole, according to a recent study.

Advertisement

A hydatidiform mole is an abnormal growth within the uterus at the beginning of pregnancy.   The tissues, which should have normally developed into the placenta (the tissue which attaches the fetus to the uterus and provides nutrition to the fetus), grow abnormally and forms a mass.

Hydatidiform mole often affects women less than 16 years or more than 45 years of age.  Symptoms include vaginal bleeding in the first three months of pregnancy.  Blood or urine tests reveal a very high level of human chorionic gonadotropin (hCG).  (hCG is the same hormone whose levels are detected during a pregnancy test).  The mole is treated with a surgical procedure called dilatation and curettage, in which the uterus is evacuated of its contents.  The abnormal tissues can then be directly examined and the diagnosis confirmed.
Advertisement

The tissue remaining in the uterus following the evacuation procedure normally regresses.  In some cases, however, this tissue may undergo cancerous changes and result in a cancer called choriocarcinoma.  Cancerous changes are detected by a rise in hCG level, thus hCG levels are regularly monitored after removal of hydatidiform mole.  Suspected cases of cancer are treated with the chemotherapy with methotrexate or dactinomycin. 

It has been suggested that women with high hCG levels beyond 6 months post evacuation of hydatidiform mole should be treated with chemotherapy drugs, even if the hCG levels are falling.  The reason behind this is, if chemotherapy is delayed beyond a certain point, it becomes more and more difficult to treat the cancer.  But is this really necessary?  Some researchers conducted a study to answer this question.

Patient data was collected from a hospital database between January 1993 and May 2008.  Patient records with persistently high hCG levels 6 months after hydatidiform mole evacuation were identified.  Some of these women underwent continued surveillance, whereas others were treated with chemotherapy.

In the women undergoing surveillance, blood and urine testing was carried out every 2 weeks till the hCG levels came back to normal.  Testing was then carried out monthly for the next 6 months.

In women who underwent chemotherapy, blood testing was done twice a week till the levels came down to normal.  Testing was then done once a week till 6 weeks following the end of chemotherapy.  At this point, the patients underwent Doppler ultrasound.  Frequency of testing was further reduced, till only urine testing every 6 months was necessary.

A total of 76 patients who had high hCG values 6 months following evacuation of hydatidiform mole were included in the study.  Among these, 66 patients underwent only continued surveillancehCG values became normal in 44 patients within 8 months of evacuation, 15 patients within 1 year, and 5 patients within 18 months.  One patient who had 3 consecutive rises in hCG level was lost to follow-up, but her levels subsequently normalized without chemotherapy and she had a normal pregnancy.  Only 1 patient continued to have persistently high levels, but she also suffered from kidney failure - the high hCG levels were due to the kidney failure and not due to cancerous changes.

Thus, despite not receiving chemotherapy at 6 months post-evacuation, none of the patients under surveillance developed cancer or had a relapse.

Ten patients with persistent hCG levels 6 months after evacuation were given chemotherapy with methotrexate and folinic acid.  (Methotrexate is curative for cancers due to hydatidiform mole.  Folinic acid is given along with methotrexate to prevent some of its side effects).  Six of these patients responded completely to treatment with a normalization of hCG levels.  In 2 patients, hCG levels came to normal after treatment was stopped, within 1 week and 1 month.  In the last 2 patients, hCG levels continued to be slightly high for 3 and 15 years.  Both these patients did well and had successful pregnancies.

Thus, in patients of hydatidiform mole with declining hCG levels at 6 months, chemotherapy may not be required.  Instead, continued surveillance in these patients may be more than enough.  This approach could especially be followed in patients not at a high risk for developing cancer. The patient can thus avoid the side effects of chemotherapy.  This approach could also enable patients to plan their next pregnancy earlier.

To decide which patients should undergo chemotherapy and which should not, a cut-off value could be marked below which chemotherapy may not be necessary.  Chemotherapy should be considered in patients with high hCG levels, with imaging tests indicating cancer or when hCG levels are consistently plateaued or rising.

Further large-scale studies are necessary to establish the findings of this study.

Reference :

Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study; Roshan Agarwal et al; The Lancet, Early Online Publication, 29 Nov 2011.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Peritoneal Cancer Rhabdomyosarcoma Melanoma Male Breast Cancer Tumor Lysis Syndrome 

Recommended Reading
Methotrexate
This medication is an antimetabolite, curative in choriocarcinoma (cancer of the tissue that ......
How Safe is HCG, the Pregnancy Hormone for Weight Loss?
Many people have been rushing to get injections of the pregnancy hormone, hCG or human chorionic ......
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of mal...
Melanoma
Melanoma is a dangerous form of skin cancer caused largely due to exposure to the sun’s damaging UV ...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Peritoneal Cancer
Peritoneal cancer is a rare cancer that develops in the peritoneum. Peritoneal cancers may be primar...
Rhabdomyosarcoma
Rhabdomyosarcoma is a rare type of cancer affecting the striated muscles. It mostly occurs in ......
Tumor Lysis Syndrome
Tumor lysis syndrome is a collection of metabolic abnormalities due to the tumor cell lysis in patie...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use